ENVERIC BIOSCIENCES, INC. Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets
ENVERIC BIOSCIENCES, INC. (ENVB) had Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets of $317.97 thousand as of 2015-09-30, per its 10-Q filed 2015-11-23.
Discontinued › Notes › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation › Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less) › Business Combination, Recognized Asset Acquired, Asset
us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets · last filed 2015-11-23
- 2015-09-30: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets $317.97K.
- 2015-06-30: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets $317.97K.
| Period end | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets |
|---|---|
| 2015-09-30 | $317.97K 10-Q · filed 2015-11-23 |
| 2015-06-30 | $317.97K 10-Q · filed 2015-08-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |